22377

    543220

    MAXHEALTH

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    MAX HEALTHCARE INS LTD Share Price Today

    MAX HEALTHCARE INS LTD is currently trading at ₹1069.7, down by ₹2.7 from the previous close. The stock touched an intraday high of ₹1084.30 and a low of ₹1067.00 during the latest trading session. Over the past one year, MAX HEALTHCARE INS LTD has delivered a loss of 15.63%, while the stock has declined 5.3% in the last one month.

    MAX HEALTHCARE INS LTD performance

    Today’s low Today’s high
    ₹ 1067.00 ₹ 1084.30
    ₹ 1071.20
    52 week low 52 week high
    ₹ 903.00 ₹ 1301.70
    ₹ 1071.20
    Open Price ₹ 1070.00
    Prev. Close ₹ 1072.40
    Volume (Shares) 458239.00
    Total traded value ₹ 4908.65
    Upper Circuit ₹ 1179.60
    Lower Circuit ₹ 965.20
    info

    Investment Returns

    Over 1 Month -5.30% Over 3 Months 5.56% Over 6 Months 3.13% Over 1 Year -15.63%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    MAX HEALTHCARE INS LTD fundamentals


    • Market cap (Cr) 1,04,351.20
    • P/E Ratio (TTM) 146.06
    • Beta 0.69
    • Book Value / share 91.84
    • Return on equity 8.32%
    • EPS (TTM) 7.49
    • Dividend yield 0.19%
    • Net profit/quarter (Cr) 203.21
    info icon alternate text
    • Market cap (Cr) 1,04,219.80
    • P/E Ratio (TTM) 146.06
    • Beta 0.62
    • Book Value / share 91.84
    • Return on equity 8.32%
    • EPS (TTM) 7.49
    • Dividend yield 0.19%
    • Net profit/quarter (Cr) 203.21
    info icon alternate text

    MAX HEALTHCARE INS LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 732.90
    Operating Expense 563.86
    Net Profit 203.21
    Net Profit Margin (%) 27.72
    Earnings Per Share (EPS) 2.09
    EBITDA 306.21
    Effective Tax Rate (%) 21.95
    Particulars DEC 2025 (Values in Cr)
    Revenue 710.91
    Operating Expense 553.40
    Net Profit 186.95
    Net Profit Margin (%) 26.29
    Earnings Per Share (EPS) 1.92
    EBITDA 272.02
    Effective Tax Rate (%) 16.98
    Particulars SEP 2025 (Values in Cr)
    Revenue 736.62
    Operating Expense 568.39
    Net Profit 160.42
    Net Profit Margin (%) 21.77
    Earnings Per Share (EPS) 1.65
    EBITDA 261.09
    Effective Tax Rate (%) 25.61
    Particulars JUN 2025 (Values in Cr)
    Revenue 694.02
    Operating Expense 550.99
    Net Profit 166.03
    Net Profit Margin (%) 23.92
    Earnings Per Share (EPS) 1.71
    EBITDA 267.56
    Effective Tax Rate (%) 25.50
    Particulars MAR 2025 (Values in Cr)
    Revenue 658.70
    Operating Expense 529.62
    Net Profit 177.39
    Net Profit Margin (%) 26.93
    Earnings Per Share (EPS) 1.82
    EBITDA 272.76
    Effective Tax Rate (%) 21.93
    Particulars MAR 2026 (Values in Cr)
    Revenue 2874.45
    Operating Expense 2236.64
    Net Profit 716.61
    Net Profit Margin (%) 24.93
    Earnings Per Share (EPS) 7.37
    EBITDA 1106.89
    Effective Tax Rate (%) 22.45
    Particulars MAR 2025 (Values in Cr)
    Revenue 2663.60
    Operating Expense 2009.79
    Net Profit 701.07
    Net Profit Margin (%) 26.32
    Earnings Per Share (EPS) 7.21
    EBITDA 1126.30
    Effective Tax Rate (%) 25.94
    Particulars MAR 2024 (Values in Cr)
    Revenue 2341.36
    Operating Expense 1742.46
    Net Profit 687.26
    Net Profit Margin (%) 29.35
    Earnings Per Share (EPS) 7.07
    EBITDA 1033.26
    Effective Tax Rate (%) 20.54
    Particulars MAR 2023 (Values in Cr)
    Revenue 1904.66
    Operating Expense 1485.69
    Net Profit 694.31
    Net Profit Margin (%) 36.45
    Earnings Per Share (EPS) 7.16
    EBITDA 728.26
    Effective Tax Rate (%) -23.29
    Particulars MAR 2022 (Values in Cr)
    Revenue 1775.36
    Operating Expense 1502.99
    Net Profit 331.52
    Net Profit Margin (%) 18.67
    Earnings Per Share (EPS) 3.43
    EBITDA 571.38
    Effective Tax Rate (%) 17.22
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 110.41
    ROE % 14.33
    ROCE % 13.72
    Total Debt to Total Equity 0.32
    EBITDA Margin 28.15
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 96.50
    ROE % 12.10
    ROCE % 13.46
    Total Debt to Total Equity 0.24
    EBITDA Margin 27.47
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 86.51
    ROE % 13.37
    ROCE % 14.96
    Total Debt to Total Equity 0.13
    EBITDA Margin 30.90
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 76.31
    ROE % 16.12
    ROCE % 13.85
    Total Debt to Total Equity 0.12
    EBITDA Margin 28.56
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 64.79
    ROE % 10.15
    ROCE % 11.09
    Total Debt to Total Equity 0.17
    EBITDA Margin 25.45
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 91.85
    ROE % 8.32
    ROCE % 10.27
    Total Debt to Total Equity 0.08
    EBITDA Margin 38.51
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 85.27
    ROE % 8.78
    ROCE % 11.64
    Total Debt to Total Equity 0.07
    EBITDA Margin 42.28
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 79.03
    ROE % 9.34
    ROCE % 11.64
    Total Debt to Total Equity 0.07
    EBITDA Margin 42.24
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 72.53
    ROE % 10.40
    ROCE % 8.49
    Total Debt to Total Equity 0.08
    EBITDA Margin 36.46
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 65.09
    ROE % 5.41
    ROCE % 6.89
    Total Debt to Total Equity 0.08
    EBITDA Margin 30.80
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 700.60
    Total Assets 17230.94
    Total Liabilities 17230.94
    Total Equity 10746.63
    Share Outstanding 97
    Price to Book Ratio 10.47
    Return on Assets (%) 8.37
    Return on Capital (%) 10.56
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 681.89
    Total Assets 15214.48
    Total Liabilities 15214.48
    Total Equity 9380.87
    Share Outstanding 97
    Price to Book Ratio 12.86
    Return on Assets (%) 7.07
    Return on Capital (%) 9.06
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1099.27
    Total Assets 11999.94
    Total Liabilities 11999.94
    Total Equity 8408.14
    Share Outstanding 97
    Price to Book Ratio 10.38
    Return on Assets (%) 8.81
    Return on Capital (%) 11.07
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1468.07
    Total Assets 10101.85
    Total Liabilities 10101.85
    Total Equity 7409.59
    Share Outstanding 97
    Price to Book Ratio 6.08
    Return on Assets (%) 10.92
    Return on Capital (%) 13.84
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 499.31
    Total Assets 9189.13
    Total Liabilities 9189.13
    Total Equity 6282.47
    Share Outstanding 96
    Price to Book Ratio 5.33
    Return on Assets (%) 6.58
    Return on Capital (%) 8.63
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 532.73
    Total Assets 10890.09
    Total Liabilities 10890.09
    Total Equity 8940.59
    Share Outstanding 97
    Price to Book Ratio 10.47
    Return on Assets (%) 6.58
    Return on Capital (%) 7.44
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 416.50
    Total Assets 9967.22
    Total Liabilities 9967.22
    Total Equity 8289.36
    Share Outstanding 97
    Price to Book Ratio 12.86
    Return on Assets (%) 7.03
    Return on Capital (%) 7.97
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 720.04
    Total Assets 9068.87
    Total Liabilities 9068.87
    Total Equity 7680.76
    Share Outstanding 97
    Price to Book Ratio 10.38
    Return on Assets (%) 7.57
    Return on Capital (%) 8.57
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1231.46
    Total Assets 8420.33
    Total Liabilities 8420.33
    Total Equity 7042.11
    Share Outstanding 97
    Price to Book Ratio 6.08
    Return on Assets (%) 8.24
    Return on Capital (%) 9.26
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 386.51
    Total Assets 7811.76
    Total Liabilities 7811.76
    Total Equity 6311.38
    Share Outstanding 96
    Price to Book Ratio 5.33
    Return on Assets (%) 4.24
    Return on Capital (%) 4.93
    Particulars MAR 2026 (Values in Cr)
    Net Income 1675.58
    Cash from Operations 2005.22
    Cash from Investing -1688.99
    Cash from Financing 59.27
    Net change in Cash 3.60
    Free Cash Flow 3489.75
    Particulars MAR 2025 (Values in Cr)
    Net Income 1406.37
    Cash from Operations 1758.90
    Cash from Investing -1610.69
    Cash from Financing -163.16
    Net change in Cash -335.89
    Free Cash Flow 2703.38
    Particulars MAR 2024 (Values in Cr)
    Net Income 1365.32
    Cash from Operations 1390.95
    Cash from Investing -1285.45
    Cash from Financing -263.74
    Net change in Cash -427.52
    Free Cash Flow 2176.90
    Particulars MAR 2023 (Values in Cr)
    Net Income 1063.72
    Cash from Operations 1370.30
    Cash from Investing -1187.01
    Cash from Financing -288.56
    Net change in Cash -266.39
    Free Cash Flow 1705.90
    Particulars MAR 2022 (Values in Cr)
    Net Income 738.90
    Cash from Operations 849.58
    Cash from Investing -763.80
    Cash from Financing -294.17
    Net change in Cash -317.45
    Free Cash Flow 1402.92
    Particulars MAR 2026 (Values in Cr)
    Net Income 924.12
    Cash from Operations 708.16
    Cash from Investing -426.01
    Cash from Financing 38.83
    Net change in Cash 116.01
    Free Cash Flow 1060.74
    Particulars MAR 2025 (Values in Cr)
    Net Income 946.72
    Cash from Operations 775.64
    Cash from Investing -869.87
    Cash from Financing -28.17
    Net change in Cash -303.72
    Free Cash Flow 1028.96
    Particulars MAR 2024 (Values in Cr)
    Net Income 864.96
    Cash from Operations 761.78
    Cash from Investing -805.64
    Cash from Financing -245.91
    Net change in Cash -438.46
    Free Cash Flow 1223.13
    Particulars MAR 2023 (Values in Cr)
    Net Income 563.14
    Cash from Operations 784.72
    Cash from Investing -842.85
    Cash from Financing -54.47
    Net change in Cash -200.85
    Free Cash Flow 905.22
    Particulars MAR 2022 (Values in Cr)
    Net Income 400.49
    Cash from Operations 490.19
    Cash from Investing -669.65
    Cash from Financing -161.48
    Net change in Cash -383.77
    Free Cash Flow 861.18
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8812.90 67.80 13.36 126715.98 6680.00 9326.80
    FORTIS MALAR HOSPITALS LIMITED 49.92 0.00 2.72 93.56 40.75 76.00
    SHREE PACETRONIX LTD. 152.75 18.23 3.21 57.28 90.00 283.15
    TRANSGENE BIOTEK LTD. 2.91 0.00 2.63 22.05 1.83 5.17
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8812.90 90.07 12.71 126715.98 6680.00 9326.80
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 37.28 0.00 -9.07 27.85 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5883.55 26.15 4.87 6436.60 5010.00 6725.00

    MAX HEALTHCARE INS LTD shareholding pattern

    Holding
    4.55%
    23.71%
    41.77%
    29.95%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    MAX HEALTHCARE INS LTD Technicals Summary

    1072.20 -0.01 redarrow
    red-green-graph indicator
    11 Bearish
    5 Bullish
    • 5 Days 1084.40
    • 26 Days 1091.70
    • 10 Days 1090.90
    • 50 Days 1077.90
    • 12 Days 1092.30
    • 100 Days 1062.90
    • 20 Days 1093.50
    • 200 Days 1064.80
    1072.00 PIVOT
    First Support 1064.50 First Resistance 1079.90 Second Support 1056.60 Second Resistance 1087.40 Third Support 1049.10 Third Resistance 1095.30
    RSI 44.26 ADX 24.08 MACD 2.64 Williams % R -88.44 Commodity Channel Index (CCI) -152.43
    Date 2026-08-06 Week 907803.00 Same Day 1173915.00 Month 936745.00
    1 Year 0.69 3 Year 0.70
    Over 1 Month
    -5.30% down
    Over 1 Year
    -15.63% down
    Over 3 Months
    5.56% down
    Over 3 Years
    22.50% down
    Over 6 Months
    3.13% down
    Over 5 Years
    30.96% down

    MAX HEALTHCARE INS LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    03 Jul 2026 2.0 Final 03 Jul 2026 Equity shares
    04 Jul 2025 1.5 Final 04 Jul 2025 Equity shares
    23 Aug 2024 1.5 Final 23 Aug 2024 Equity shares
    08 Sep 2023 1.0 Final 08 Sep 2023 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    03 Jul 2026 2.0 Final 03 Jul 2026 Equity shares
    04 Jul 2025 1.5 Final 04 Jul 2025 Equity shares
    23 Aug 2024 1.5 Final 23 Aug 2024 Equity shares
    08 Sep 2023 1.0 Final 08 Sep 2023 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Max Healthcare Institute Ltd?

    Answer Field

    Max Healthcare Institute Ltd share price is for NSE ₹ 1,069.70 & for BSE ₹ 1,069.90 as on Aug 07 2026 02:48 PM.

    What is the Market Cap of Max Healthcare Institute Ltd Share?

    Answer Field

    The market cap of Max Healthcare Institute Ltd for NSE ₹ 0.01 & for BSE ₹ 0.01 as on Aug 07 2026 02:48 PM.

    What is the 52 Week High and Low of Max Healthcare Institute Ltd?

    Answer Field

    The 52 Week High and Low of Max Healthcare Institute Ltd for NSE is ₹ 1,301.70 and ₹ 903.00 and for BSE is ₹ 1,301.95 and ₹ 903.50.

    What is 1 year return for Max Healthcare Institute Ltd?

    Answer Field

    The 1 year returns on the stock has been -15.63%.

    What is the P/E Ratio of Max Healthcare Institute Ltd Share?

    Answer Field

    As on Aug 07 2026 02:48 PM the price-to-earnings (PE) ratio for Max Healthcare Institute Ltd share is 146.06.

    What is the PB ratio of Max Healthcare Institute Ltd Share?

    Answer Field

    As on Aug 07 2026 02:48 PM, the price-to-book (PB) ratio for Max Healthcare Institute Ltd share is 91.84.

    How to Buy Max Healthcare Institute Ltd Share?

    Answer Field

    You can trade in Max Healthcare Institute Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Max Healthcare Institute Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Max Healthcare Institute Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Max Healthcare Institute Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |